Sun Pharmaceutical Industries’ manufacturing facility in Halol in
Gujarat is undergoing a surprise audit by the US Food and Drug
Administration (US FDA). The move may have been triggered by a number of
recent recalls from the plant. The plant contributes to around 40% of
US sales and around 25% of consolidated profit of the company. Real Time News & Trading Trends Keep Liking Epic Research Private Limited
Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+
For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co
No comments:
Post a Comment